Buscador de publicaciones

Publicaciones

  • Luciano JV, Carlos Garcia Forero, Marta Cerdà Lafont, Peñarrubia-María MT, Fernández-Vergel R, JOSE MIGUEL RUIZ MARTIN, Rozadilla A, Sirvent Alierta, Elena, Santo Panero, Pilar, García Campayo, Javier, Serrano-Blanco A and Rubio-Valera M.

    Functional Status, Quality of Life, and Costs Associated With Fibromyalgia Subgroups: A Latent Profile Analysis.

    CLINICAL JOURNAL OF PAIN . 32(10): 829-840. Nº de citas: 33

    [doi:10.1097/AJP.0000000000000336]

  • Gumà-Uriel L, Peñarrubia-María MT, Cerdà-Lafont M, Cunillera-Puertolas O, Almeda-Ortega J, Fernández-Vergel R, García-Campayo J and Luciano JV.

    Impact of IPDE-SQ personality disorders on the healthcare and societal costs of fibromyalgia patients: a cross-sectional study.

    BMC FAMILY PRACTICE . 17(1): 61-61. Nº de citas: 9

    [doi:10.1186/s12875-016-0464-5]

  • Rubio-Valera M, Peñarrubia-María MT, Fernández-Vergel R, Carvajal Tejadillo AC, Fernández A, Aznar-Lou I, March-Pujol M and Serrano-Blanco A.

    Impact of pharmaceutical intervention in preventing relapses in depression in Primary Care

    ATENCION PRIMARIA . 48(5): 308-315. Nº de citas: 4

    [doi:10.1016/j.aprim.2015.05.009]

  • Rubio-Valera M, Beneitez I, Peñarrubia-María MT, Luciano JV, Mendive JM, McCrone P, Knapp M, Sabés-Figuera R, Katarzyna Kocyan, García-Campayo J and Serrano-Blanco A.

    Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study).

    BMC Psychiatry . 15(1): 63-63. Nº de citas: 10

    [doi:10.1186/s12888-015-0448-3]

  • Luciano JV, D Amico F, Cerdà-Lafont M, Peñarrubia-María MT, Knapp M, Cuesta-Vargas AI, Serrano-Blanco A and García-Campayo J.

    Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.

    ARTHRITIS RESEARCH & THERAPY . 16(5): 451-451. Nº de citas: 37

    [doi:10.1186/s13075-014-0451-y]

  • Rubio-Valera M, March Pujol M, Fernández A, Peñarrubia-María MT, Travé P, López Del Hoyo Y and Serrano-Blanco A.

    Evaluation of a pharmacist intervention on patients initiating pharmacological treatment for depression: A randomized controlled superiority trial

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 23(9): 1057-1066. Nº de citas: 45

    [doi:10.1016/j.euroneuro.2012.11.006]

  • Cuesta-Vargas A, Luciano JV, Peñarrubia-María MT, García-Campayo J, Fernández-Vergel R, Arroyo-Morales M and Serrano-Blanco A.

    Clinical dimensions of fibromyalgia symptoms and development of a combined index of severity: the CODI index.

    QUALITY OF LIFE RESEARCH . 22(1): 153-160. Nº de citas: 5

    [doi:10.1007/s11136-012-0134-6]

  • Luciano JV, Sabes R, Cardeñosa E, Peñarrubia-María MT, Fernández-Vergel R, Garcia-Campayo, Javier, Martin Knapp and Serrano-Blanco A.

    Cost-Utility of a Psychoeducational Intervention in Fibromyalgia Patients Compared With Usual Care An Economic Evaluation Alongside a 12-Month Randomized Controlled Trial

    CLINICAL JOURNAL OF PAIN . 29(8): 702-711. Nº de citas: 46

  • Luciano JV, Martínez N, Peñarrubia-María MT, Fernández-Vergel R, García-Campayo J, Verduras C, Blanco ME, Jiménez M, Ruiz JM, López del Hoyo Y and Serrano-Blanco A.

    Effectiveness of a psychoeducational treatment program implemented in general practice for fibromyalgia patients: a randomized controlled trial.

    CLINICAL JOURNAL OF PAIN . 27(5): 383-391. Nº de citas: 44

    [doi:10.1097/AJP.0b013e31820b131c]

  • Fernández A, Pinto-Meza A, Bellón JA, Roura-Poch P, Haro JM, Autonell J, Palao DJ, Peñarrubia-María MT, Fernández R, Blanco E, Luciano JV and Serrano-Blanco A.

    Is major depression adequately diagnosed and treated by general practitioners? Results from an epidemiological study.

    GENERAL HOSPITAL PSYCHIATRY . 32(2): 201-209. Nº de citas: 79

    [doi:10.1016/j.genhosppsych.2009.11.015]